Pharma
Times
Virupaksha Organics Ltd. has established itself as a trusted name in the global pharmaceutical market, specializing in the production of Fluconazole, a critical antifungal medication used to treat a wide range of fungal infections. With state-of-the-art manufacturing facilities located in Telangana, India, the company adheres to the highest standards of quality, safety, and regulatory compliance to produce high-purity Fluconazole for both domestic and international markets.
Fluconazole is widely prescribed to treat conditions like candidiasis and cryptococcal meningitis, and Virupaksha Organics’ commitment to producing this essential API ensures a reliable supply to healthcare providers worldwide. The company’s facilities are WHO-GMP, ISO 9001, and ISO 14001 certified, reflecting its dedication to maintaining excellence in manufacturing while also being environmentally conscious.
By leveraging cutting-edge technology and a robust research and development process, Virupaksha continues to meet the growing global demand for Fluconazole, ensuring that patients receive effective and affordable treatment. As part of its mission to be a research-driven pharmaceutical company, Virupaksha Organics remains a trusted partner for pharmaceutical companies around the globe, delivering high-quality APIs with a focus on customer satisfaction and sustainability.
With its expanding global footprint, Virupaksha Organics Ltd. is poised to remain at the forefront of the pharmaceutical industry, particularly in the production of vital medications like Fluconazole, helping to combat fungal infections and improve health outcomes worldwide.
Latest Update
- Charminar to Remain Closed on Sept.6
- MP Judge Gets Rs 500-cr Extortion Threat Via Post; Police Suspect UP Link
- Andhra Clears Rs 856-cr Incentive for India's Largest Printed Circuit Board Plant
- Rahul Gandhi Raises FRA Violation Fears in Rs 72,000-cr Great Nicobar Project
- Ganesh Laddu Auctioned for Record Rs 51 Lakh in Hyderabad’s My Home Bhuja
- Nalgonda Fisheries Officer in ACB Net
- Man in Hyderabad Loses Rs.7.60 lakh in WhatsApp Investment Scam
- UAE Names 17-Member Squad to Take on India, Pakistan in Asia Cup
- Centre Seeks SC Transfer of Pleas Against Online Gaming Act to Avoid Conflicting Rulings
- 2 Persons in Nalgonda Get 20 Years of RI in Separate POCSO Cases
- Kerala to Lose Rs 8,000-10,000 Cr Annually Due to GST Rate Rationalisation: FM Balagopal
- Unethical Pharma Practices: SC Asks if Existing Norms Are Being Implemented
- Indian-America NASA Veteran Appointed Associate Administrator of Space Agency
- Rajinikanth's Coolie Set for Digital Premiere on Prime Video
- Meet Hyderabad Engineer Dressing India's Workforce for Danger
- Kerala faces Rs 8,000–10,000 crore revenue loss after GST rate cuts: FM Balagopal
- DRDO transfers three advanced materials technologies to the industry
- Witness Blood Moon over Hyderabad’s skies on September 7
- Nalgonda Fisheries Officer caught taking Rs 20,000 bribe
- Congress president Mallikarjun Kharge calls GST revamp ‘1.5’, insists wait for ‘true GST 2.0’ continues
- No explicit mention of corruption in Ghose Commission Report: V Prakash Rao
- Hyderabad woman nearly dies after betel nut lodges in airway
- Nalgonda man gets 22 years jail for raping minor girl
- ANMs protest in Hyderabad demanding regularisation and better pay
- Murali Mohan launches ‘Kallu Kottu Kada’ song from Mutton Soup
- Hyderabad: Devotees throng Khairatabad for glimpse of Ganesh on last day of darshan
- Chaos in Bengal Assembly as TMC, BJP MLAs clash over Suvendu Adhikari suspension
- Amit Shah to join Ganesh immersion procession in Hyderabad on September 6
- Rahul Gandhi flags FRA violations in clearances for Great Nicobar Project
- India and Singapore strengthen ties with new strategic roadmap, says PM Modi